Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode

Inclusion Criteria: * Men with obstructive symptoms due to benign prostatic hyperplasia who are also on anticoagulant regimen. * Anticoagulant regiments include: Aspirin 81mg, Aspirin 325mg, Adenosine diphosphate (ADP) receptor inhibitors, Cilostazol, Dabigatran, Dipyridamole, or Warfarin. The patient will be stable on their dosage regimen for at least 3 months. * Maximum flow rate \<15ml/s by uroflowmetry. * International Prostate Symptom Score (IPSS)≥10. Exclusion Criteria: * Patients with coagulopathy, INR exceeding 3. * Anti-coagulation dose changes within 3 months of surgery. * Patients not medically cleared to undergo surgery for medical reasons. * Patients with neurogenic bladder (bladder affected due to a neurologic cause). * Urethral stricture, obstruction due to stricture. * Suspected bladder or prostate cancer. * Prostate size greater than 80 cc.